ArticleAntimicrobial agents and chemotherapy2026
Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical
Julia Noack et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.